InvestorsObserver
×
News Home

Should You Buy Cassava Sciences Inc (SAVA) Stock After it Has Risen 9.93% in a Week?

Monday, September 14, 2020 09:47 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Cassava Sciences Inc (SAVA) Stock After it Has Risen 9.93% in a Week?

The market has been high on Cassava Sciences Inc (SAVA) stock recently. SAVA gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Cassava Sciences Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SAVA!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With SAVA Stock Today?

Cassava Sciences Inc (SAVA) stock is unchanged 0% while the S&P 500 is up 0.05% as of 4:00 PM on Friday, Sep 11. SAVA is unmoved $0.00 from the previous closing price of $3.32 on volume of 18,413,936 shares. Over the past year the S&P 500 has risen 11.44% while SAVA is up 161.42%. SAVA lost -$0.22 per share in the over the last 12 months.

To see InvestorsObserver's Sentiment Score for Cassava Sciences Inc click here.

More About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. It is also developing an experimental biomarker diagnostic PTI-125 to detect Alzheimer's disease with the help of a blood test.

Click Here to get the full Stock Score Report on Cassava Sciences Inc (SAVA) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App